Articles tagged with Cancer Patients
A study published in JAMA Oncology found that 10% of CLL patients discontinued ibrutinib therapy due to disease progression. Patients who experienced Richter's transformation or progressive CLL had poorer outcomes and required alternative therapy quickly after discontinuation.
Researchers have identified two urinary biomarkers that can predict bladder cancer-specific survival and guide treatment. The study validated the biomarkers in over 400 clinical samples, showing they are independent predictors of cancer prognosis.
A study published in JAMA Oncology found that patients with advanced cancer perceived a higher level of compassion from physicians when presented with an optimistically framed message about future treatment options. The results suggest the need for extra support and care for delivering bad news while preserving hope.
Researchers deciphered the signaling pathways associated with immortal cells, which work in parallel to suppress terminal differentiation. The discovery enables the use of purified proteins to reduce contamination and accelerate clinical application.
Pediatric cancer patients who receive antibiotics within 60 minutes of reporting fever and neutropenia have decreased intensive care consultation rates and lower mortality. The study shows that timely antibiotic delivery can lead to significant reductions in hospitalization and fatalities among pediatric cancer patients.
Researchers from Dartmouth's Norris Cotton Cancer Center have discovered the Cherenkov Effect can be measured to improve radiation therapy. The study found that light emission correlates with dose, making it suitable for narrow beam stereotactic radiation therapy and surface dosimetry applications.
A new TGen study finds targeting stroma surrounding cancer cells can improve treatments and extend patient survival in pancreatic cancer patients. High levels of stroma correlate with poor patient survival, with median survival rates ranging from 9-24 months depending on hyaluronan and collagen levels.
A new study found that cancer patients' preferences for involving family members in treatment decisions differ significantly by ethnic background, marital status, sex, age, and insurance status. Non-English speaking Asian patients and Spanish-speaking Hispanic patients were more likely to share decision-making with their families.
Patients with locally advanced kidney cancer did not experience improved outcomes from adjuvant treatment with sorafenib or sunitinib. The average disease recurrence period was similar between those receiving the drugs and those on placebo, suggesting that these treatments may not be beneficial for this patient group.
A study of 945 patients with intermediate-risk prostate cancer found nearly four-fold higher mortality risk within 15 years compared to low-risk patients. The analysis suggests that active surveillance may not be suitable for all intermediate-risk patients, emphasizing the need for personalized treatment approaches.
A study reveals that hematopoietic stem cells are vulnerable to DNA damage when rapidly dividing under stress conditions. This can lead to premature aging and increase the risk of cancer.
A study by Brigham and Women's Hospital researchers uses epigenomic maps to predict a cancer's cell type of origin, providing new insights into early cancer events. This discovery could help guide treatment decisions for patients with unknown primary sites, which pose significant challenges.
Researchers have found that mutations in the PTEN gene lead to reduced activity and stability of a critical protein, promoting genetic instability and disease. This discovery could pave the way for new treatments for patients with both autism and cancer.
A study found that TERT mRNA levels are highly predictive of aggressive bladder cancers, allowing doctors to recommend targeted treatments and improve patient outcomes. The study also suggests that telomerase reactivation is crucial for the progression of bladder cancers, highlighting a potential target for disease intervention.
Researchers at UT Southwestern Medical Center found that acetate supplements accelerate tumor growth and metastasis in mice. The study suggests that modulating acetate production could be a key to designing therapies for cancer patients.
A survey of 2500 Dutch doctors found that 86% would consider helping a patient to die under certain circumstances. Attitudes towards euthanasia and assisted suicide varied by condition, with most willing to help patients with cancer or other physical diseases, but fewer for those with mental illnesses.
Researchers discovered a key pathway driving tumour growth in bile duct cancer and found that blocking it can prevent cancer cell growth and shrink tumours. The treatment is already being tested in patients with other cancers and shows promise as a potential breakthrough for this devastating disease.
Researchers have identified a new biomarker that can help identify patients who are more likely to respond to certain chemotherapies. MAGE-A3/6 genes contribute to tumor growth by inhibiting AMPK, a protein that controls cellular energy levels and suppresses cancerous tumors.
The 44th annual Barrett-Jackson Scottsdale Auction raised $140,000 for TGen's colon and prostate cancer research. The event featured a '79 Cutlass sold by actress Sharon Stone, previously raising over $600,000 for TGen.
A new study of cancer patient-clinician encounters found that only a small percentage of patients requested clinically inappropriate tests or treatments. Most requests were for imaging studies, laboratory tests, or palliative care interventions, with few requesting chemotherapy or proton beam therapy.
Research presented at the American Stroke Association's International Stroke Conference 2015 found that stroke survivors have a higher annual rate of age-adjusted cancer incidence compared to the general population. Additionally, stroke survivors who develop cancer are more than three times likely to die compared to those without cancer.
Patients who preferred physician-controlled decisions had lower reported quality of care compared to those with shared decision-making. Patients' reports about the quality of their care are increasingly important health care performance measures.
Researchers at A*STAR's Genome Institute of Singapore have developed an expert system called OncoIMPACT that combines cancer omics data with machine learning models to predict treatment targets. The system has been applied to over a thousand cancers, including melanomas and ovarian cancers, and shows promise for personalized medicine.
Researchers found that certain HPV+ oropharyngeal cancer patients can survive for over two years without further disease after intensive treatment. The study identified key factors contributing to the survival advantage, including cancer sensitivity to radiotherapy and chemotherapy.
Researchers have developed a revolutionary model to study hematopoiesis in living organisms, revealing that at least one-third of blood stem cells produce differentiated progenitor cells. The study also shows that mature blood cells are supplied by first progenitor cells that regenerate themselves over time.
A new radiotracer has been developed to accurately identify the sentinel node in head and neck squamous cell carcinoma, reducing the need for extensive surgery. The study shows a high detection rate and low false negative rate for SNs, facilitating accurate prediction of cancer spread.
A study of 5,050 patient-clinician encounters found that only 1% were clinically inappropriate, and physicians complied with fewer than 1 in 10 requests. The findings challenge the myth of the 'demanding patient' and suggest a need to redirect attention from unnecessary costs.
New research suggests that cancer false alarms could lead to patients delaying symptom checks due to a lack of support. A systematic review found that over-reassurance and under-support can discourage patients from seeking help for new or recurrent symptoms.
A study found that young adult survivors (18-39) report higher distress levels than older survivors, despite similar time since treatment completion. Fear of cancer recurrence and financial burden were key predictors of elevated distress in these young adults.
Researchers found higher proportions of women and young adults dying of mesothelioma in two counties encompassing Las Vegas, suggesting naturally occurring mineral fibers are a contributing source. The study highlights the need for more research to reduce exposure.
A new $10 million research program aims to investigate and experimentally validate nutritional interventions, develop reliable DNA tests, and introduce new cancer prevention strategies to the general public and policymakers. Research suggests that more than half of all colon cancers can be prevented through dietary and behavioral inter...
Researchers at the University of Minnesota Academic Health Center have developed a new reporter system to study bone regeneration potential in human embryonic stem cells. The system allows for better monitoring of cell properties and may lead to the creation of new therapies for diseases such as leukemia or genetic blood disorders.
The center aims to provide clinical care and research using heavy particles for innovative new cancer treatments, offering a more potent and precise therapy than conventional options. The project is expected to create 130 high-level jobs and generate over $600 million in economic impact for Texas.
A recent study by UT Southwestern Medical Center found that patients with a prior cancer diagnosis have similar clinical outcomes to those without a history of cancer. The researchers studied over 102,000 patients and found that these patients had better overall survival and lung cancer-specific survival rates.
A new study from Columbia University Medical Center has found that a drug targeting the fused protein in glioblastoma may lead to significant clinical improvement and tumor reduction. The research suggests that developing a more precise drug could result in better treatment outcomes for patients with brain cancer.
A recent study found that nearly a third of women with N2/N3 breast cancer did not receive post-mastectomy radiation therapy (PMRT), which is the standard of care for this patient group. The study evaluated over 57,000 cases and found that socioeconomic factors did not influence PMRT receipt.
A new study has identified eight specific physical signs associated with imminent death in cancer patients, including non-reactive pupils and drooping of the nasolabial fold. These signs can help healthcare professionals make a diagnosis of impending death, allowing for more informed decisions about treatment and care.
A study by MD Anderson researchers identified eight physical and cognitive signs associated with imminent death in cancer patients. These signs include nonreactive pupils, decreased response to verbal and visual stimuli, and upper gastrointestinal bleeding, which could help clinicians communicate with patients and families, as well as ...
Researchers at NIH identified chromothripsis as the reason for a patient's spontaneous cure of WHIM syndrome. The study showed that a random deletion of mutant CXCR4 gene in stem cells led to normal neutrophil function.
Two-thirds of primary care health professionals want to widen exemption criteria for long-term conditions and lower or abolish charges altogether. The current system is seen as a barrier that prevents some people from receiving necessary prescriptions.
A new Special Issue from ecancermedicalscience tackles fertility-sparing cancer treatments, collecting latest research on preserving fertility in breast, cervical and ovarian cancers. Fertility-sparing treatments balance patient's wishes with oncological outcomes.
A new forecast from Cancer Research UK suggests that 1 in 2 people in the UK will develop cancer at some point in their lives. The increased risk is primarily due to more people living into older age, when cancer is more common.
Researchers at Ohio State University identified three genes that enable glioblastoma stem-like cells to survive radiation therapy. MELK and EZH2 proteins form a complex that drives EZH2 expression, promoting tumor development and progression.
A study reveals children with 'biallelic mismatch repair deficiency' (bMMRD) experience a rapid wave of genetic mutations, dubbed the 'great flood', which causes aggressive cancer. The research identifies a previously undiscovered mechanism for cancer progression and potential targets for treatment.
New review highlights advances in image-guided surgery using fluorescence imaging to improve cancer detection and patient survival. Innovative strategies in low-income countries, such as mosquito net repairs and task redistribution, offer lessons for high-income countries.
Researchers at Moffitt Cancer Center discovered six microRNAs that can distinguish between high-risk and low-risk pancreatic lesions, offering a promising biomarker for early detection. This finding may lead to the development of a microRNA-based blood test to aid in predicting disease severity and foster new prevention strategies.
A retrospective cohort study found that metformin use was associated with a decreased risk of lung cancer in diabetic patients who had never smoked. Nonsmokers taking metformin for five years or longer showed a 52% reduction in lung cancer risk, but this finding was not statistically significant.
A new study published in Diabetologia found that cancer patients with diabetes have significantly lower medication adherence rates compared to those without diabetes. The research revealed that the type and stage of cancer had a significant impact on medication adherence, with more advanced cancers resulting in substantially lower rates.
The GW Cancer Institute will launch a yearlong study to gather key information about barriers encountered by patients with cancer, create evaluation tools for patient navigation at the community level, and translate research findings for practice-based audiences.
A survey of 364 medical journalists found that direct contact with physicians is the most reliable source of information for creating accurate cancer news. Medical journalists also rely on social media and personal connections to support their research, highlighting the need for responsible healthcare reporting.
Patients with a history of smoking have increased risks of cancer relapse, side effects, and death from prostate cancer, according to a study published in BJU International. Smoking negatively affects prostate cancer health outcomes, particularly when treated with radiotherapy.
A targeted magnetic resonance/ultrasound fusion biopsy detected more high-risk prostate cancers and fewer low-risk cancers compared to standard biopsy. The study found that adding standard biopsy to targeted biopsy provided limited benefits in detecting additional high-risk tumors.
A team of scientists from Georgetown University and Virginia Tech developed a mathematical model to understand breast cancer cell decisions, revealing a key molecular component that determines resistance to antiestrogen therapy. The study found that interferon regulatory factor-1 (IRF1) promotes resistance to antiestrogens.
A new analysis found that women with breast cancer have poor knowledge about their illness, with minority patients less likely to know accurate information. The study highlights the need for patient education and provider awareness to improve informed treatment decisions and overall cancer care.
A Cancer Research UK study found that people who dismiss their symptoms as trivial or worry about wasting the doctor's time may delay cancer diagnosis. The study discovered that many individuals with red-flag cancer warning symptoms felt they didn't need medical attention, fearing it would be seen as a sign of weakness.
Researchers used denoising autoencoders to effectively extract key biological principles from breast cancer gene expression data, resulting in gene expression features that generalize across studies and represent important clinical factors.
A team of researchers has developed a platform to rapidly identify effective drug combinations for lung cancer patients with resistant tumors. The NFCR-supported study uses cells taken from patient tumors and treats them with various drug combinations to find the most effective treatments.
The American Society of Clinical Oncology (ASCO) announces its cancer Advance of the Year, four new treatments improving outlook for patients with chronic lymphocytic leukemia (CLL). New therapies include immunotherapy drugs and molecularly targeted drugs offering more effective treatment options.
The SPECTAcolor platform has successfully implemented across 19 European clinical centers, recruiting over 500 patients and providing high-quality biological materials. Preliminary analysis reveals mutations in key cancer biomarkers, including KRAS, NRAS, BRAF, PI3K, and mismatch repair.
Researchers found that inactive EGFR is involved in autophagy, a process where cells consume nonessential contents to survive. Cancer cells use this process to thrive under stressful conditions. Combining drugs that block autophagy with those that inactivate EGFR could be an effective way to treat cancers